R. Verbeeck

European Journal of Clinical Pharmacology · 2008

A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom R. Verbeeck trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Stevens
  2. Josef Coresh
  3. A. Levey
  4. Chi‐Yuan Wu
  5. Tom Greene

Papers from R. Verbeeck's perspective

Ordered by how strongly the researchers R. Verbeeck trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Assessing kidney function--measured and estimated glomerular filtration rate. (New England Journal of Medicine)
  2. Prevalence of chronic kidney disease in the United States. (Journal of the American Medical Association (JAMA))
  3. Model for end-stage liver disease (MELD) and allocation of donor livers. (Gastroenterology)
  4. Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System (Pharmaceutical Research)
  5. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans.
  6. Cystatin C as a marker of GFR--history, indications, and future research. (Clinical Biochemistry)
  7. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
  8. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. (Journal of the American Medical Association (JAMA))
  9. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  10. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research,… (Circulation)

Their papers